{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:22:32Z","timestamp":1759134152307,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T00:00:00Z","timestamp":1466726400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Departamento de Industria e Innovaci\u00f3n. Gobierno de Arag\u00f3n","award":["B01"],"award-info":[{"award-number":["B01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10620-016-4225-z","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T18:43:36Z","timestamp":1466880216000},"page":"2896-2907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-3445","authenticated-orcid":false,"given":"Elena","family":"Piazuelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Esquivias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Cebri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Santander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Emperador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Asunci\u00f3n","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Carrera-Lasfuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,24]]},"reference":[{"key":"4225_CR1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","volume":"265","author":"WJ Blot","year":"1991","unstructured":"Blot WJ, Devessa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287\u20131289.","journal-title":"JAMA"},{"key":"4225_CR2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/jnci\/djn211","volume":"100","author":"LM Brown","year":"2008","unstructured":"Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184\u20131187.","journal-title":"J Natl Cancer Inst"},{"key":"4225_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ije\/29.4.645","volume":"29","author":"AA Botterweck","year":"2000","unstructured":"Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645\u2013654.","journal-title":"Int J Epidemiol"},{"key":"4225_CR4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstr\u00f6m R, Lindgren A, Nyr\u00e9n O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825\u2013831.","journal-title":"N Engl J Med"},{"key":"4225_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF01354551","volume":"8","author":"HJ Stein","year":"1993","unstructured":"Stein HJ, Siewert JR. Barrett\u2019s esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8:276\u2013288.","journal-title":"Dysphagia"},{"key":"4225_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.11029","volume":"105","author":"AP Polednak","year":"2003","unstructured":"Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105:98\u2013100.","journal-title":"Int J Cancer"},{"key":"4225_CR7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","volume":"97","author":"SS Husain","year":"2002","unstructured":"Husain SS, Szabo IL, Tarnawski AS. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol. 2002;97:542\u2013553.","journal-title":"Am J Gastroenterol"},{"key":"4225_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10:501\u2013507.","journal-title":"Lancet Oncol"},{"key":"4225_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"DA Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47\u201356.","journal-title":"Gastroenterology"},{"key":"4225_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.21814","volume":"119","author":"V Jayaprakash","year":"2006","unstructured":"Jayaprakash V, Menezes RJ, Javle MM, et al. Regular aspirin use and esophageal cancer risk. Int J Cancer. 2006;119:202\u2013207.","journal-title":"Int J Cancer"},{"key":"4225_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31\u201341.","journal-title":"Lancet"},{"key":"4225_CR12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bjc.1997.42","volume":"75","author":"JC Rockett","year":"1997","unstructured":"Rockett JC, Larkin K, Darnton SJ, Morris AG, Matthews HR. Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer. 1997;75:258\u2013263.","journal-title":"Br J Cancer"},{"key":"4225_CR13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.prostaglandins.2006.09.002","volume":"81","author":"E Piazuelo","year":"2006","unstructured":"Piazuelo E, Jim\u00e9nez P, Strunk M, et al. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett\u2019s esophagus. Prostaglandins Other Lipid Mediat. 2006;81:150\u2013161.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4225_CR14","first-page":"527","volume":"40","author":"S Santander","year":"2012","unstructured":"Santander S, Cebri\u00e1n C, Esquivias P, et al. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice. Int J Oncol. 2012;40:527\u2013534.","journal-title":"Int J Oncol"},{"key":"4225_CR15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0016-5085(98)70305-1","volume":"114","author":"CJ Barnes","year":"1998","unstructured":"Barnes CJ, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology. 1998;114:873\u2013877.","journal-title":"Gastroenterology"},{"key":"4225_CR16","first-page":"511","volume":"23","author":"S Bousserouel","year":"2010","unstructured":"Bousserouel S, Gosse F, Bouhadjar M, Soler L, Marescaux J, Rau F. Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. Oncol Rep. 2010;23:511\u2013517.","journal-title":"Oncol Rep"},{"key":"4225_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2007","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2007;22:659\u2013666.","journal-title":"FASEB J"},{"key":"4225_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/oxfordjournals.annonc.a058872","volume":"5","author":"SP Langdon","year":"1994","unstructured":"Langdon SP, Hendriks HR, Braakhuis BJ, et al. Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study. Ann Oncol. 1994;5:415\u2013422.","journal-title":"Ann Oncol"},{"key":"4225_CR19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<891::AID-IJC22>3.0.CO;2-6","volume":"73","author":"WJ Jansen","year":"1997","unstructured":"Jansen WJ, Kolfschoten GM, Erkelens CA, Van Ark-Otte J, Pinedo HM, Boven E. Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma. Int J Cancer. 1997;73:891\u2013896.","journal-title":"Int J Cancer"},{"key":"4225_CR20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.39.5.654","volume":"39","author":"AI Lanas","year":"1996","unstructured":"Lanas AI, Arroyo MT, Esteva F, Cornudella R, Hirschowitz BI, S\u00e1inz R. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut. 1996;39:654\u2013660.","journal-title":"Gut"},{"key":"4225_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.seminoncol.2014.04.012","volume":"41","author":"B Pasche","year":"2014","unstructured":"Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol. 2014;41:397\u2013401.","journal-title":"Semin Oncol"},{"key":"4225_CR22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamainternmed.2013.14544","volume":"174","author":"AI Neugut","year":"2014","unstructured":"Neugut AI. Aspirin as adjuvant therapy for stage III colon cancer: standard of care? JAMA Intern Med. 2014;174:739\u2013741.","journal-title":"JAMA Intern Med"},{"key":"4225_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308260","author":"P Li","year":"2014","unstructured":"Li P, Wu H, Zhang H, et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. 2014. doi: 10.1136\/gutjnl-2014-308260 .","journal-title":"Gut"},{"key":"4225_CR24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2011.289","volume":"105","author":"RE Langley","year":"2011","unstructured":"Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MK, Venning G. Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer. 2011;105:1107\u20131113.","journal-title":"Br J Cancer"},{"key":"4225_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCO.0000000000000098","volume":"26","author":"RE Langley","year":"2014","unstructured":"Langley RE, Rothwell PM. Aspirin in gastrointestinal oncology: new data on an old friend. Curr Opin Oncol. 2014;26:441\u2013447.","journal-title":"Curr Opin Oncol"},{"key":"4225_CR26","doi-asserted-by":"crossref","first-page":"e2988","DOI":"10.1136\/bmj.e2988","volume":"344","author":"Z Kmietowicz","year":"2012","unstructured":"Kmietowicz Z. Study finds possible role for aspirin as treatment for colon cancer. BMJ. 2012;344:e2988.","journal-title":"BMJ"},{"key":"4225_CR27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302:649\u2013658.","journal-title":"JAMA"},{"key":"4225_CR28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2012.101","volume":"106","author":"E Bastiaannet","year":"2012","unstructured":"Bastiaannet E, Sampieri K, Dekkers OM, et al. Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer. 2012;106:1564\u20131570.","journal-title":"Br J Cancer"},{"key":"4225_CR29","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jgs.12033","volume":"60","author":"MS Reimers","year":"2012","unstructured":"Reimers MS, Bastiaannet E, van Herk-Sukel MP, et al. Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study. J Am Geriatr Soc. 2012;60:2232\u20132236.","journal-title":"J Am Geriatr Soc"},{"key":"4225_CR30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.gastro.2013.11.005","volume":"146","author":"CR Cardwell","year":"2014","unstructured":"Cardwell CR, Kunzmann AT, Cantwell MM, et al. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort. Gastroenterology. 2014;146:700\u2013708.","journal-title":"Gastroenterology"},{"key":"4225_CR31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28:1467\u20131472.","journal-title":"J Clin Oncol"},{"key":"4225_CR32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1245\/s10434-009-0382-z","volume":"16","author":"JF Liu","year":"2009","unstructured":"Liu JF, Jamieson GG, Wu TC, Zhu GJ, Drew PA. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. Ann Surg Oncol. 2009;16:1397\u20131402.","journal-title":"Ann Surg Oncol"},{"key":"4225_CR33","doi-asserted-by":"crossref","first-page":"e48208","DOI":"10.1371\/journal.pone.0048208","volume":"7","author":"S Pathi","year":"2012","unstructured":"Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PLoS ONE. 2012;7:e48208.","journal-title":"PLoS ONE"},{"key":"4225_CR34","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.18632\/oncotarget.3171","volume":"6","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu L, Fan P, et al. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Oncotarget. 2015;6:9999\u201310015.","journal-title":"Oncotarget"},{"key":"4225_CR35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3892\/ijo.2011.1304","volume":"40","author":"MA Hossain","year":"2012","unstructured":"Hossain MA, Kim DH, Jang JY, et al. Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol. 2012;40:1298\u20131304.","journal-title":"Int J Oncol"},{"key":"4225_CR36","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","volume":"126","author":"C Patrono","year":"2004","unstructured":"Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:234S\u20132364S.","journal-title":"Chest"},{"key":"4225_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2000","unstructured":"Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2000;10:181\u2013193.","journal-title":"Nat Rev Cancer"},{"key":"4225_CR38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.bpg.2012.10.001","volume":"26","author":"A Bruno","year":"2012","unstructured":"Bruno A, Dovizio M, Tacconelli S, Patrignani P. Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2012;26:e1\u2013e13.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4225_CR39","first-page":"209","volume":"3","author":"TO Frommel","year":"1997","unstructured":"Frommel TO, Dyavanapalli M, Oldham T, et al. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients. Clin Cancer Res. 1997;3:209\u2013213.","journal-title":"Clin Cancer Res"},{"key":"4225_CR40","first-page":"311","volume":"8","author":"CJ Barnes","year":"1999","unstructured":"Barnes CJ, Hamby-Mason RL, Hardman WE, Cameron IL, Speeg KV, Lee M. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. Cancer Epidemiol Biomarkers Prev. 1999;8:311\u2013315.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4225-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4225-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T02:05:25Z","timestamp":1568081125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4225-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,24]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4225-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2016,6,24]]}}}